Skye Bioscience, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized
Skye Bioscience, Inc. (SKYE) had Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized of 300.00 million shares as of 2026-05-26, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized · last filed 2026-08-14
- 2026-05-26: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 300.00M shares.
- 2026-05-25: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 100.00M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized |
|---|---|
| 2026-05-26 | 300.00M shares 10-Q · filed 2026-08-14 |
| 2026-05-25 | 100.00M shares 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |